Celera Genomics Revenues and Losses Fall in Q2 of 2004 | GenomeWeb

NEW YORK, Jan. 28 (GenomeWeb News) - Celera Genomics reported decreased revenues and net losses for its fiscal year 2004 second quarter today, accompanied by smaller R&D spending.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: carbapenem resistance in Enterobacteriaceae, selection against educational attainment-linked variants, and more.

Technology Review points out that a new US presidential science advisor hasn't been selected.

Researchers find that blood tests might be able to help determine severity of a concussion, Wired reports.

President-elect Donald Trump considers other candidates for director of the National Institutes of Health, Nature News reports.